Month: March 2017

Home / 2017 / March
Post

Alzheimer’s Clinical Research Studies Offer People The Opportunity To Try New Approaches To The Treatment Of Alzheimer’s Disease That Are Not Yet Available To The General Public

As written previously, there is currently no FDA approved treatment that can reverse, arrest or even slow the damage and destruction of brain cells and their connections that is caused by Alzheimer’s disease.  While there are drugs approved by the FDA to treat Alzheimer’s disease, these drugs can only provide limited and relatively short-lived symptomatic relief...